HIGHLIGHTS
- who: Li-Ching Lin and collaborators from the Frontiers Media SA, SwitzerlandUniversity College of Medicine, Taoyuan, Taiwan, Division of Hematology-Oncology, Department have published the research work: Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience, in the Journal: (JOURNAL)
SUMMARY
Ripretinib, GIST, compassionate use, advanced, metastatic A Corrigendum on Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience by Lin L-C, Huang W-K, Yen C-C, Yang C-Y, Sung M-T, Wong NSM, Chua . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.